Dan Hartman

Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization

Vincent I. Ahonkhai, Samuel Martins, Alexandre Portet et al. · PLoS ONE · 2016 · 70 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +17

DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease

Stan Heptinstall, David Iyú, Panagiotis Manolopoulos et al. · Platelets · 2008 · 68 citations

Medicine, Pharmacology, Pharmacotherapy +17

Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line

Iruvanti Sunitha, Deborah L. Meighen, Dan Hartman et al. · Clinical & Experimental Metastasis · 1994 · 36 citations

Life Sciences, Cancer Biology, Cell Biology +8

Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y₁₂antagonist both<i>in-vitro</i>and<i>ex-vivo</i>in human volunteers

Sue Fox, Jane May, Andrew J. Johnson et al. · Platelets · 2012 · 32 citations

Medicine, Hematology, Pharmacology +17

Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report

Jennifer Cable, Anthony S. Fauci, William E. Dowling et al. · Annals of the New York Academy of Sciences · 2022 · 12 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17